Clinical Trials Directory

Trials / Unknown

UnknownNCT06027333

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Berner Reha Zentrum AG · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Patients with fibrotic insterstitial lung disease (ILD) participating in inpatient rehabilitation or in outpatient pulmonary care will be invited to participate in this observational study. Patients will fill out questionnaire regarding quality of life and symptoms at baseline and follow-up (at the end of rehabilitation or after the second outpatient ILD consultation). Additionally, clinical data obtained in clinical routine or for the IIP registry will be used for this project. The aim is to assess changes in self-efficacy and quality of life over time and to establish a control cohort for a later feasibility study on a educational and self-management intervention (currently in planning).

Conditions

Interventions

TypeNameDescription
BEHAVIORALinpatient rehabilitationThis is an uncontrolled observational study on patients undergoing usual care in pulmonary rehabilitation and care

Timeline

Start date
2023-11-08
Primary completion
2024-08-30
Completion
2024-08-30
First posted
2023-09-07
Last updated
2024-03-13

Locations

2 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT06027333. Inclusion in this directory is not an endorsement.

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease (NCT06027333) · Clinical Trials Directory